O'Regan R - Search Results

1

The impact of skin-sparing mastectomy with immediate reconstruction in patients with Stage III breast cancer treated with neoadjuvant chemotherapy and postmastectomy radiation.

Prabhu R, Godette K, Carlson G, Losken A, Gabram S, Fasola C, O'Regan R, Zelnak A, Torres M. Prabhu R, et al. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e587-93. doi: 10.1016/j.ijrobp.2011.09.024. Epub 2011 Dec 22. Int J Radiat Oncol Biol Phys. 2012. PMID: 22197232

2

Progress in systemic adjuvant therapy of early-stage breast cancer.

Gradishar WJ, O'Regan RM. Gradishar WJ, et al. Int J Clin Oncol. 2003 Aug;8(4):239-47. doi: 10.1007/s10147-003-0338-4. Int J Clin Oncol. 2003. PMID: 12955580 Review.

3

Chemoprevention of breast cancer.

Zelnak AB, O'Regan RM. Zelnak AB, et al. Curr Probl Cancer. 2004 Jul-Aug;28(4):201-17. doi: 10.1016/j.currproblcancer.2004.05.007. Curr Probl Cancer. 2004. PMID: 15318323 Review. No abstract available.

4

Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer.

Kudachadkar R, O'Regan RM. Kudachadkar R, et al. CA Cancer J Clin. 2005 May-Jun;55(3):145-63. doi: 10.3322/canjclin.55.3.145. CA Cancer J Clin. 2005. PMID: 15890638 Free article. Review.

5

Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancer.

O'Regan RM, Von Roenn JH, Carlson RW, Malik U, Sparano JA, Staradub V, Khan S, Jovanovic B, Morrow M, Gradishar WJ. O'Regan RM, et al. Clin Breast Cancer. 2005 Jun;6(2):163-8. doi: 10.3816/CBC.2005.n.019. Clin Breast Cancer. 2005. PMID: 16001995 Clinical Trial.

6

Targeting angiogenesis in advanced breast cancer.

Zelnak AB, O'Regan RM. Zelnak AB, et al. BioDrugs. 2007;21(4):209-14. doi: 10.2165/00063030-200721040-00001. BioDrugs. 2007. PMID: 17628118 Review.

7

Adjuvant hormonal therapy for early-stage breast cancer.

Zelnak AB, O'Regan R. Zelnak AB, et al. Cancer Treat Res. 2008;141:63-78. doi: 10.1007/978-0-387-73161-2_5. Cancer Treat Res. 2008. PMID: 18274083 Review. No abstract available.

8

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW. Lund MJ, et al. Breast Cancer Res Treat. 2009 Jan;113(2):357-70. doi: 10.1007/s10549-008-9926-3. Epub 2008 Mar 7. Breast Cancer Res Treat. 2009. PMID: 18324472

9

Endocrine therapy for the treatment of postmenopausal women with breast cancer.

Harichand-Herdt S, Zelnak A, O'Regan R. Harichand-Herdt S, et al. Expert Rev Anticancer Ther. 2009 Feb;9(2):187-98. doi: 10.1586/14737140.9.2.187. Expert Rev Anticancer Ther. 2009. PMID: 19192957 Review.

10

Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer.

Rizzo M, Lund MJ, Mosunjac M, Bumpers H, Holmes L, O'Regan R, Brawley OW, Gabram S. Rizzo M, et al. Cancer. 2009 Jul 1;115(13):3009-15. doi: 10.1002/cncr.24334. Cancer. 2009. PMID: 19466698 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters